These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3543143)

  • 21. The use of skin substrates deficient in basement membrane molecules for the diagnosis of subepidermal autoimmune bullous disease.
    Vodegel RM; Kiss M; Cjm De Jong M; Pas HH; Altmayer A; Molnar K; Husz S; Van Der Meer JB; Jonkman MF
    Eur J Dermatol; 1998 Mar; 8(2):83-5. PubMed ID: 9649654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of the epidermolysis bullosa acquisita antigen by LH 7.2 monoclonal antibody: use in diagnosis.
    Tatnall FM; Whitehead PC; Black MM; Wojnarowska F; Leigh IM
    Br J Dermatol; 1989 Apr; 120(4):533-9. PubMed ID: 2730844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of extracellular and intracellular bullous pemphigoid antigens at the dermal-epibolic junction in organ culture of human skin.
    Ikeda S; Yaguchi H; Ogawa H
    J Invest Dermatol; 1990 Mar; 94(3):336-40. PubMed ID: 2407787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bullous pemphigoid and epidermolysis bullosa acquisita. Differentiation by fluorescence overlay antigen mapping.
    De Jong MC; Bruins S; Heeres K; Jonkman MF; Nieboer C; Boorsma DM; Pas HH; van der Meer JB
    Arch Dermatol; 1996 Feb; 132(2):151-7. PubMed ID: 8629822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A mouse monoclonal antibody against a newly discovered basement membrane component, the epidermolysis bullosa acquisita antigen.
    Paller AS; Queen LL; Woodley DT; Gammon WR; O'Keefe EJ; Briggaman RA
    J Invest Dermatol; 1985 Mar; 84(3):215-7. PubMed ID: 3882847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimal conditions of 1 M NaCl splitting technique to demonstrate basement membrane zone antigens in bullous pemphigoid, epidermolysis bullosa acquisita and linear IgA bullous dermatoses.
    Jenkins RE; Rodenas J; Bhogal BS; Black MM
    Dermatology; 1994; 189 Suppl 1():133-4. PubMed ID: 8049556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered skin basement membrane antigenicity in epidermolysis bullosa.
    Fine JD
    Curr Probl Dermatol; 1987; 17():111-26. PubMed ID: 3297501
    [No Abstract]   [Full Text] [Related]  

  • 28. Anti-basement membrane autoantibodies in patients with anti-epiligrin cicatricial pemphigoid bind the alpha subunit of laminin 5.
    Kirtschig G; Marinkovich MP; Burgeson RE; Yancey KB
    J Invest Dermatol; 1995 Oct; 105(4):543-8. PubMed ID: 7561156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skin explant culture: a reliable method for detecting pemphigoid antibodies in pemphigoid sera that are negative by standard immunofluorescence and immunoblotting.
    Mutasim DF; Vaughan A; Supapannachart N; Farooqui J
    J Invest Dermatol; 1993 Oct; 101(4):624-7. PubMed ID: 8409535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A practical technique for differentiation of subepidermal bullous diseases: localization of in vivo-bound IgG by laser scanning confocal microscopy.
    Wozniak K; Kazama T; Kowalewski C
    Arch Dermatol; 2003 Aug; 139(8):1007-11. PubMed ID: 12925388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin.
    Gammon WR; Briggaman RA; Inman AO; Queen LL; Wheeler CE
    J Invest Dermatol; 1984 Feb; 82(2):139-44. PubMed ID: 6363567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-epiligrin cicatricial pemphigoid and epidermolysis bullosa acquisita: differentiation by use of indirect immunofluorescence microscopy.
    Vodegel RM; de Jong MC; Pas HH; Yancey KB; Jonkman MF
    J Am Acad Dermatol; 2003 Apr; 48(4):542-7. PubMed ID: 12664017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of antibodies to type VII and type IV collagen laminin and amnion as epidermal basement membrane markers.
    Kirkham N; Gibson B; Leigh IM; Price ML
    J Pathol; 1989 Sep; 159(1):5-6. PubMed ID: 2681626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita.
    Woodley DT; Briggaman RA; O'Keefe EJ; Inman AO; Queen LL; Gammon WR
    N Engl J Med; 1984 Apr; 310(16):1007-13. PubMed ID: 6369131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence that anti-basement membrane zone antibodies in bullous eruption of systemic lupus erythematosus recognize epidermolysis bullosa acquisita autoantigen.
    Gammon WR; Woodley DT; Dole KC; Briggaman RA
    J Invest Dermatol; 1985 Jun; 84(6):472-6. PubMed ID: 3889170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunofluorescence mapping of antigenic determinants within the dermal-epidermal junction in the mechanobullous diseases.
    Hintner H; Stingl G; Schuler G; Fritsch P; Stanley J; Katz S; Wolff K
    J Invest Dermatol; 1981 Feb; 76(2):113-8. PubMed ID: 6161971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acquired bullous diseases of childhood: re-evaluation of diagnosis by indirect immunofluorescence examination on 1 M NaCl split skin and immunoblotting.
    Kirtschig G; Wojnarowska F; Marsden RA; Edwards S; Bhogal B; Black MM
    Br J Dermatol; 1994 May; 130(5):610-6. PubMed ID: 8204469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 19-DEJ-1, a hemidesmosome-anchoring filament complex-associated monoclonal antibody. Definition of a new skin basement membrane antigenic defect in junctional and dystrophic epidermolysis bullosa.
    Fine JD; Horiguchi Y; Couchman JR
    Arch Dermatol; 1989 Apr; 125(4):520-3. PubMed ID: 2649012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidermolysis bullosa acquisita antigen and the carboxy terminus of type VII collagen have a common immunolocalization to anchoring fibrils and lamina densa of basement membrane.
    Shimizu H; McDonald JN; Gunner DB; Black MM; Bhogal B; Leigh IM; Whitehead PC; Eady RA
    Br J Dermatol; 1990 May; 122(5):577-85. PubMed ID: 2354110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defining target antigens in linear IgA disease using skin from subjects with inherited epidermolysis bullosa as a substrate for indirect immunofluorescence microscopy.
    Harman KE; Bhogal BS; Eady RA; McGrath JA; Black MM
    Br J Dermatol; 1999 Sep; 141(3):475-80. PubMed ID: 10583051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.